Established in 2011, this Danish-based MedTech manufacturer specializes in developing, manufacturing, and commercializing innovative substance-based medical devices and cosmetics containing bioactive cannabidiol (CBD) derived from the Cannabis sativa L. plant. As a CTD dossier owner and manufacturer, it holds GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Europe, the United States, India, Australia, and Israel.

This company is a B2B supplier of unique, high-quality pharmaceutical products including Food for Special Medical Purposes (FSMP), food supplements, and medical devices. Their product portfolio spans diverse therapeutic areas such as gynecology/women's health, pediatrics, gastroenterology, orthopedics, CNS disorders, and respiratory diseases. They offer a range of dosage forms like tablets, capsules, topical gels, stickpacks, controlled release tablets, nasal sprays, and oral sprays. Efficacy and safety are supported by clinical trials and EFSA claims. Manufacturing is handled by European GMP and/or HACCP-approved factories, ensuring high quality. They provide complete EU Regulatory dossiers and regulatory support, offering both their own brand products and private label options.